Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Apr 30, 2026
ProShares UltraPro Russell 2000 (URTY): Positioning for Small-Cap Momentum in 2026

ProShares UltraPro Russell 2000 (URTY): Positioning for Small-Cap Momentum in 2026

Key Takeaways

  • Anticipated Federal Reserve rate cuts could amplify URTY's performance through heightened sensitivity to lower borrowing costs for small-cap firms.
  • Small-cap earnings growth projections for 2026 exceed large-cap estimates, positioning the Russell 2000 for potential outperformance.
  • Portfolio exposure to domestic-focused small-caps offers opportunities from policy tailwinds like deregulation, though tariff risks loom.
  • Strong equity ETF inflows in early 2026 signal investor rotation toward small-caps, potentially boosting leveraged funds like URTY.
  • Quarterly index rebalances and earnings seasons serve as key catalysts for volatility and directional moves in the underlying Russell 2000 Index.
  • Leveraged structure magnifies both upside from sector cycles in financials and industrials, and downside risks from economic slowdowns.

Understanding URTY's Portfolio Exposure and ETF Strategy

The ProShares UltraPro Russell 2000 (URTY) is a leveraged exchange-traded fund designed to deliver three times (3x) the daily performance of the Russell 2000 Index, which tracks approximately 2,000 U.S. small-cap stocks by market capitalization. In my analysis, this strategy relies on financial derivatives like swaps and futures rather than direct stock holdings, allowing for efficient exposure with a net expense ratio of 0.95% and assets under management around $332 million.

From what I see, the underlying index offers broad small-cap diversification, with top sector exposures in financial services (about 17%), industrials (16%), healthcare (16%), and information technology (14%). Its geographic focus remains overwhelmingly U.S.-centric, highlighting domestic revenue streams that are less vulnerable to global trade disruptions. One thing that stands out is URTY's daily reset mechanism, which makes it well-suited for short-term tactical trades to capture small-cap rallies from economic recovery or sector rotations, though it also amplifies risks during extended downturns.

Key Catalysts on the Horizon

Upcoming Federal Reserve policy meetings could bring further interest rate reductions, which I view as a major boost for small-caps carrying higher debt loads than large-caps—lower rates ease refinancing costs and lift profitability, and with URTY's 3x leverage, this effect gets magnified. Small-cap earnings seasons in Q2 and Q3 2026 present another opportunity, as consensus forecasts point to stronger growth than mega-caps, which could trigger index breakouts.

Policy shifts like tariff implementations and deregulation efforts should play to the Russell 2000's domestic strengths. FTSE Russell's quarterly index rebalances add buying pressure to qualifying small-caps, while ETF inflows into small-cap products topped $500 billion industry-wide in Q1 2026, fueling momentum—though risk-off outflows remain a concern. I also checked Tickeron’s AI Screener to compare how these small-caps stack up against peers. Inflation trends and GDP releases will shape sentiment too, with solid growth favoring cyclical sectors like industrials and financials.

Sector, Index, and Macro Outlook

In my view, the Russell 2000's path depends heavily on a softening rate environment, where easing cycles have historically benefited small-caps via cheaper capital and valuation expansions. Moderating inflation could allow the Fed to cut rates to 3.00%-3.25% by year-end, easing strains on rate-sensitive areas like financials and real estate in the index.

U.S. economic expansion, bolstered by fiscal stimulus, supports small-cap cyclicals in industrials and consumer discretionary. Financials show resilience through regional banks, and healthcare benefits from innovation trends. Market rotations away from large-cap tech persist, as seen in the index's robust Q1 2026 performance, though global risks and currency moves could limit upside. Overall, these macro tailwinds seem aligned for small-cap breadth, making URTY's leveraged setup compelling amid wider market participation.

Tickeron’s Trend Prediction Engine

I rely on Tickeron’s AI Trend Prediction Engine for forecasting potential bullish, bearish, or sideways moves in ETFs like URTY over the next week or month. It analyzes massive datasets to detect emerging trends, breakout or reversal signals, and delivers predictions across thousands of instruments, with searchable categories, historical context, and customizable alerts. This tool has helped me stay proactive in volatile markets, providing data-driven insights for tactical decisions.

Long-Term Outlook and Structural Shifts

Over the longer term, small-cap growth draws on the historical equity risk premium, with Russell 2000 stocks outperforming in expansions. Sector shifts—like technology uptake in agile small firms and healthcare demand from demographics—point to sustained strength. Normalizing rate cycles ultimately favor debt-laden small-caps, and global flows into U.S. domestic assets reinforce the index.

Market structure changes, including active ETF inflows approaching $400 billion yearly, signal broader participation beyond mega-caps. Key holdings in industrials and financials gain from infrastructure and deregulation. This constructive backdrop supports patient, diversified small-cap exposure, but for leveraged plays like URTY, I'm watching volatility closely and stressing risk management.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: URTY

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


URTY's Stochastic Oscillator is sitting in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

URTY moved above its 50-day moving average on August 21, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for URTY crossed bullishly above the 50-day moving average on August 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where URTY advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on URTY as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for URTY turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where URTY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

URTY broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for URTY entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Guardant Health (NASDAQ:GH), Arrowhead Pharmaceuticals (NASDAQ:ARWR), SSR Mining (NASDAQ:SSRM), Transocean Ltd (NYSE:RIG), Lumen Technologies (NYSE:LUMN), Valaris Limited (NYSE:VAL), Abercrombie & Fitch Co (NYSE:ANF), California Resources Corp (NYSE:CRC), Tanger (NYSE:SKT).

Industry description

The investment seeks daily investment results that correspond to three times (3x) the daily performance of the Russell 2000® Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of the small-cap segment of the U.S. markets. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Market Cap

The average market capitalization across the ProShares UltraPro Russell2000 ETF is 2.58B. The market cap for tickers in the group ranges from 455.89K to 59.33B. BE holds the highest valuation in this group at 59.33B. The lowest valued company is ZSPC at 455.89K.

High and low price notable news

The average weekly price growth across all stocks in the ProShares UltraPro Russell2000 ETF was 117%. For the same ETF, the average monthly price growth was 140%, and the average quarterly price growth was 785%. SKYE experienced the highest price growth at 347%, while BRCC experienced the biggest fall at -90%.

Volume

The average weekly volume growth across all stocks in the ProShares UltraPro Russell2000 ETF was 11%. For the same stocks of the ETF, the average monthly volume growth was 2% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 56
Price Growth Rating: 51
SMR Rating: 74
Profit Risk Rating: 75
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
URTY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
ProShares UltraPro Russell 2000 (URTY): Positioning for Small-Cap Momentum in 2026